RU2010132620A - METHOD OF IMMUNOTHERAPY OF KIDNEY CELL CANCER - Google Patents
METHOD OF IMMUNOTHERAPY OF KIDNEY CELL CANCER Download PDFInfo
- Publication number
- RU2010132620A RU2010132620A RU2010132620/14A RU2010132620A RU2010132620A RU 2010132620 A RU2010132620 A RU 2010132620A RU 2010132620/14 A RU2010132620/14 A RU 2010132620/14A RU 2010132620 A RU2010132620 A RU 2010132620A RU 2010132620 A RU2010132620 A RU 2010132620A
- Authority
- RU
- Russia
- Prior art keywords
- reaferon
- body temperature
- information
- immunotherapy
- degeneration
- Prior art date
Links
Abstract
Способ иммунотерапии почечно-клеточного рака, включающий внутримышечное введение иммуномодулирующего препарата реаферон, отличающийся тем, что оптимальную стартовую дозу реаферона подбирают индивидуально для каждого больного методом электропунктурной диагностики по Р.Фоллю, когда информационно-волновые маркеры температуры тела человека 37,5 и 38,0°С и дозы реаферона 1, 2, 3 и более млн. ЕД тестируют по отдельности на контрольных точках измерения меридианов лимфатической системы, нервной дегенерации, кровообращения, эпителиальной и паренхиматозной дегенерации, аллергии, тройного обогревателя и выбирают ту дозу реаферона, при совместном, одновременном тестировании которой с информационно-волновыми маркерами температуры тела 37,5 или 38,0°С показатели шкалы прибора для электропунктурной диагностики по Р.Фоллю, будут равны 50-60 условных единиц измерения. A method for immunotherapy of renal cell carcinoma, including intramuscular administration of the immunomodulatory drug reaferon, characterized in that the optimal starting dose of reaferon is selected individually for each patient by the method of electropuncture diagnostics according to R. Voll, when information-wave markers of human body temperature are 37.5 and 38.0 °C and doses of reaferon 1, 2, 3 and more million units are tested separately at the control points for measuring the meridians of the lymphatic system, nervous degeneration, blood circulation, epithelial and parenchymal degeneration, allergies, triple heater and choose the dose of reaferon, with joint, simultaneous testing which with information-wave markers of body temperature of 37.5 or 38.0 ° C, the scale indicators of the device for electropuncture diagnostics according to R. Voll will be equal to 50-60 conventional units of measurement.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010132620/14A RU2449770C2 (en) | 2010-08-03 | 2010-08-03 | Method of immunotherapy of rhenal cell carcinoma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010132620/14A RU2449770C2 (en) | 2010-08-03 | 2010-08-03 | Method of immunotherapy of rhenal cell carcinoma |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2010132620A true RU2010132620A (en) | 2012-02-10 |
RU2449770C2 RU2449770C2 (en) | 2012-05-10 |
Family
ID=45853232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2010132620/14A RU2449770C2 (en) | 2010-08-03 | 2010-08-03 | Method of immunotherapy of rhenal cell carcinoma |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2449770C2 (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2055604C1 (en) * | 1993-09-13 | 1996-03-10 | Сергей Иванович Петренко | Device for changing activity of biological cell |
RU2065297C1 (en) * | 1995-05-25 | 1996-08-20 | Юрий Валентинович Готовский | Method for diagnosing and treating living organisms |
RU2105566C1 (en) * | 1995-06-06 | 1998-02-27 | Юрий Андреевич Севрук | Method for carrying out interferon therapy |
RU2199356C2 (en) * | 2000-11-13 | 2003-02-27 | Петренко Сергей Иванович | Method and device for recording polarized electromagnetic radiation of inactivated pathogenic organisms to chip, method for eliminating pathogenic organisms strain from animal or human organism |
RU2293564C2 (en) * | 2005-02-17 | 2007-02-20 | Борис Насимович Фузайлов | Method for diagnosis and treatment of malignant tumor |
RU2314123C2 (en) * | 2005-12-14 | 2008-01-10 | ГУ научно-исследовательский институт медицинских проблем Севера СО РАМН (РФ) | Method for individually selecting and adjusting interferon dose in renal carcinoma patients |
FR2913019A1 (en) * | 2007-02-23 | 2008-08-29 | Cerep Sa | New substituted heterocyclic compounds useful for treating/preventing cancer e.g. prostate, lung, breast, colon, skin, kidney and bone cancer, psoriasis, rheumatoid arthritis, Kaposis sarcoma, atherosclerosis and autoimmune diseases |
-
2010
- 2010-08-03 RU RU2010132620/14A patent/RU2449770C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2449770C2 (en) | 2012-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2014016014A (en) | Methods for determining drug efficacy using cereblon-associated proteins. | |
WO2015003015A3 (en) | Apparatuses for home use in determining tissue wetness | |
BR112016005802A2 (en) | chlorotoxin conjugates and methods of use | |
TR201905612T4 (en) | Conjugates of proteins and polyvalent cell-penetrating peptides and their uses. | |
MX2015014486A (en) | Markers of tumor cell response to anti-cancer therapy. | |
NZ603780A (en) | Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer | |
WO2013071012A3 (en) | Personalized strategic cancer treatment | |
BR112015002706A8 (en) | NICLOSAMIDE AND ITS DERIVATIVES FOR USE IN THE TREATMENT OF SOLID TUMORS | |
EA201401353A1 (en) | BIOMARKERS TO DETERMINE AN EFFECTIVE RESPONSE RESPONSE TO THE TREATMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) | |
Sampath et al. | Multimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular response | |
Huhndorf et al. | Systematic brain tumor conductivity study with optimized EPT sequence and reconstruction algorithm | |
BR112015006848A2 (en) | pharmaceutical formulation, weight loss induction method, body fat reduction method, food intake reduction method, method for improving glucose homeostasis, and method for preventing an increase in body mass index of a normal, preterm patient. obese, obese or morbidly obese. | |
Wang et al. | Sorafenib induces renal cell carcinoma apoptosis via upregulating activating transcription factor 4 | |
RU2010132620A (en) | METHOD OF IMMUNOTHERAPY OF KIDNEY CELL CANCER | |
Ueshima et al. | A case of the transversus abdominis plane block in a super obese patient using a convex probe | |
FR3001626B1 (en) | NON-INVASIVE METHOD FOR MEASURING THE STATE OF TISSUE PERFUSION | |
RU2013124435A (en) | METHOD FOR DIAGNOSTIC OF TUMOR TUMORS | |
Ng et al. | Dynamic-contrast-enhanced MRI and dynamic tensor Imaging (DTI) for the early detection of anti-angiogenic effect and vessel “normalization” in human breast cancer treated with neoadjuvant chemotherapy | |
Brunner et al. | 14 T NMR and 7 T MRI in vitro investigation of cold stimulation of abdominal WAT, inguinal WAT and BAT | |
Gupta et al. | A method for correcting T1 maps of prostate at 3T obtained by variable flip angle imaging | |
Bhattacharyya et al. | Functional MRI using implanted stereotactic EEG electrodes---heating investigation for safety | |
Sah et al. | Cut-off values of the absolute concentration of total choline for the differentiation of early breast cancer, locally advanced breast cancer, benign and normal breast tissues using proton in vivo MRS in large cohort of women | |
Jiang et al. | Early detection of treatment-induced apoptosis in tumors using temporal diffusion spectroscopy MRI | |
Min et al. | Prediction of the psychological fear on pain sensitivity | |
RU2009123207A (en) | METHOD FOR DETERMINING HUMAN PSYCHOPHYSIOLOGICAL CONSTITUTION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20120804 |